![Sacha Mann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sacha Mann
Directeur/Membre du Conseil chez
Blue Mesa Health, Inc.
Profil
Sacha Mann is the founder of Diadem Biotherapeutics, Inc. Current jobs include Director at Blue Mesa Health, Inc. since 2018, Director at Egle Therapeutics SAS, Director at hC Bioscience, Inc. since 2021, Director at Larkspur Biosciences, Inc., and Partner at SilverArc Capital Management LLC (Venture Capital) starting in 2026.
Former jobs include Senior Investment Director & Partner at Takeda Ventures, Inc. from 2021 to 2026, and Investment Manager at Archangel Investors Ltd. from 2007 to 2009.
Education includes graduate studies at The Johns Hopkins University, undergraduate and graduate degrees from the University of British Columbia, and an MBA from Simon Fraser University.
Postes actifs de Sacha Mann
| Sociétés | Poste | Début |
|---|---|---|
Blue Mesa Health, Inc.
 Blue Mesa Health, Inc. BiotechnologyHealth Technology Delivers digital behavior change programs to support the prevention diabetes and other chronic diseases | Directeur/Membre du Conseil | 01/01/2018 |
Egle Therapeutics SAS
 Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Directeur/Membre du Conseil | - |
Hc Bioscience, Inc.
 Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapy drugs | Directeur/Membre du Conseil | 01/12/2021 |
Larkspur Biosciences, Inc.
 Larkspur Biosciences, Inc. BiotechnologyHealth Technology Develops immunotherapies to outsmart cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Sacha Mann
| Sociétés | Poste | Fin |
|---|---|---|
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Private Equity Investor | 06/05/2026 |
Archangel Investors Ltd.
 Archangel Investors Ltd. Investment ManagersFinance Archangel Investors invests in companies located in Scotland, UK. The firm focuses on technology and life sciences sectors. It provides financing in the form of equity and debt for start-up, early stage and expansion capital requirements ranging between GBP 50k-2 million. | Corporate Officer/Principal | 01/01/2009 |
Diadem Biotherapeutics, Inc.
 Diadem Biotherapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that focuses on creating bio-therapeutically materials produced using organic means | Fondateur | - |
Formation de Sacha Mann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
Archangel Investors Ltd.
Archangel Investors Ltd. Investment ManagersFinance Archangel Investors invests in companies located in Scotland, UK. The firm focuses on technology and life sciences sectors. It provides financing in the form of equity and debt for start-up, early stage and expansion capital requirements ranging between GBP 50k-2 million. | Finance |
Blue Mesa Health, Inc.
Blue Mesa Health, Inc. BiotechnologyHealth Technology Delivers digital behavior change programs to support the prevention diabetes and other chronic diseases | Health Technology |
Diadem Biotherapeutics, Inc.
Diadem Biotherapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that focuses on creating bio-therapeutically materials produced using organic means | Health Technology |
Egle Therapeutics SAS
Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Health Technology |
Hc Bioscience, Inc.
Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapy drugs | Health Technology |
Larkspur Biosciences, Inc.
Larkspur Biosciences, Inc. BiotechnologyHealth Technology Develops immunotherapies to outsmart cancer | Health Technology |
